AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
AtriCure (ATRC) Tops Q2 EPS by 4c
July 29, 2025 4:04 PM EDTAtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.13), $0.04 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $136.1 million versus the consensus estimate of $130.17 million.
GUIDANCE:
AtriCure sees FY2025 EPS of ($0.39)-($0.34), versus the consensus of ($0.51). AtriCure sees... More
